Literature DB >> 3510981

Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells.

M R Hidore, J W Murphy.   

Abstract

Previous reports demonstrate that natural killer (NK) cells inhibit the growth of Cryptococcus neoformans in vitro, but conclusive evidence supporting the effectiveness of NK cells in host resistance to cryptococci is not available. The objective of these studies was to assess the ability of NK cells to clear C. neoformans from the lungs, livers, and spleens of infected mice. CBA/J mice were depleted of NK cells, as well as other natural effector cells, by an intraperitoneal injection of cyclophosphamide (Cy), 240 mg/kg of body weight. One day later, 7.5 X 10(7) nylon wool-nonadherent (NWN) spleen cells, either untreated or treated with anti-asialo GM1 and complement to remove NK cells, were adoptively transferred to Cy-pretreated mice. On day 2 after Cy treatment, the mice were injected intravenously with 2 X 10(4) cryptococci. At 4 and 6 days after Cy treatment, tissues were assayed for NK reactivity, using a 4-h 51Cr-release assay, and for in vivo clearance of cryptococci as reflected by mean log10 CFU per organ. We observed that Cy treatment depleted NK activity against YAC-1 targets and reduced in vivo clearance of C. neoformans from the tissues of infected mice. Additionally, Cy treatment depleted the total lung and spleen cellularity and the total number of peripheral blood lymphocytes when compared with those in normal untreated control mice. Also, spleen weights were significantly decreased in comparison with those of untreated animals 4 days after Cy treatment. Adoptive transfer of untreated NWN spleen cells into Cy-depressed mice restored the NK cell activity which correlated with enhanced clearance of cryptococci from lungs, livers, and spleens. In contrast, treatment of NWN spleen cells with anti-asialo GM1 and complement before adoptive transfer abrogated the ability of these cells to restore NK activity or reduce the numbers of cryptococci present in tissues of infected mice. Taken together, these data indicate that NK cells are the cells effective in diminishing the numbers of cryptococci in tissues of infected mice. Consequently, NK cells may play a role in first-line host resistance against C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510981      PMCID: PMC262374          DOI: 10.1128/iai.51.2.547-555.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

2.  Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.

Authors:  R D Diamond; R K Root; J E Bennett
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

3.  Resistance against Cryptococcus conferred by intracellular bacteria and protozoa.

Authors:  L O Gentry; J S Remington
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

4.  Phagocytosis of Cryptococcus neoformans by alveolar macrophages.

Authors:  G S Bulmer; J R Tacker
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

5.  The role of NK cells in resistance of in vivo tumors.

Authors:  K Okumura; S Habu; M Kasai
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

6.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.

Authors:  R B Herberman; M E Nunn; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

7.  In vitro effects of natural killer cells against Paracoccidioides brasiliensis yeast phase.

Authors:  B E Jimenez; J W Murphy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.

Authors:  R H Wiltrout; R B Herberman; S R Zhang; M A Chirigos; J R Ortaldo; K M Green; J E Talmadge
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

9.  In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.

Authors:  T G Mitchell; L Friedman
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

10.  Intracellular fate of Cryptococcus neoformans.

Authors:  J R Tacker; F Farhi; G S Bulmer
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

View more
  29 in total

Review 1.  Host-parasite interaction in fungal infections.

Authors:  N Khardori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

2.  Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody.

Authors:  M F Miller; T G Mitchell; W J Storkus; J R Dawson
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.

Authors:  S M Levitz; M P Dupont
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells.

Authors:  E Blasi; R Mazzolla; R Barluzzi; P Mosci; F Bistoni
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Growth inhibition of Candida albicans by interleukin-2-activated splenocytes.

Authors:  D W Beno; H L Mathews
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Natural killer cells mediate protection induced by a Salmonella aroA mutant.

Authors:  R Schafer; T K Eisenstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice.

Authors:  M F Lipscomb; T Alvarellos; G B Toews; R Tompkins; Z Evans; G Koo; V Kumar
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

8.  Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans.

Authors:  E Blasi; R Barluzzi; R Mazzolla; F Bistoni
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Phagocyte-mediated killing of Candida tropicalis.

Authors:  R A Lindemann; C K Franker
Journal:  Mycopathologia       Date:  1991-02       Impact factor: 2.574

10.  In vitro and in vivo antifungal activities of BMY-28864, a water-soluble pradimicin derivative.

Authors:  M Kakushima; S Masuyoshi; M Hirano; M Shinoda; A Ohta; H Kamei; T Oki
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.